Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

SC Pharmaceuticals Inc (SCPH)

15.1 0.1 (0.67%)

02-23 14:44

Open:

14.95

Pre. Close:

15

High:

15.1

Low:

14.9

Volume:

5,439

Market Cap:

279M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.348 - 15.444

15.444 - 15.512

Low:

14.476 - 14.594

14.594 - 14.677

Close:

14.844 - 15.018

15.018 - 15.141

Technical analysis  (as of: 2018-02-23 1:44:09 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 18.63     One year: 21.76

Support:

Support1: 13.21    Support2: 11.52

Resistance:

Resistance1: 15.95    Resistance2: 18.63

Pivot:

13.28

Moving Averages:

MA(5): 14.85     MA(20): 13.13

MA(100):     MA(250):

MACD:

MACD(12,26): 0.53     Signal(12,26,9): 0.18

%K %D:

%K(14,3): 79.98     %D(3): 80.42

RSI:

RSI(14): 70.18

52-Week:

High: 18.17  Low: 11.5  Change(%): -39.6

Average Vol(K):

3-Month: 3395  10-Days 3273

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SCPH has closed below upper band by 15.8%. Bollinger Bands are 0% narrower than normal.

Headline News

Tue, 06 Feb 2018 12:56:15 GMT
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global ...

Thu, 02 Nov 2017 12:33:45 GMT
scPharmaceuticals Announces FDA Acceptance of NDA for Furoscix (subcutaneous ...

Wed, 20 Dec 2017 15:56:15 GMT
scPharmaceuticals Inc. (Nasdaq: SCPH) to Ring The Nasdaq Stock Market Closing Bell

Thu, 15 Feb 2018 18:33:45 GMT
ScPharmaceuticals: Time For The PDUFA Run-Up

Fri, 10 Nov 2017 17:37:30 GMT
scPharmaceuticals Sets Terms For $96 Million IPO

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Delivery Systems

Shares Out. (M)

17.61

Shares Float (M)

17.54

% Held by Insiders

0.40

% Held by Institutions

21.80

Shares Short (K)

31

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

-2.628

Book Value (p.s.)

12.410

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-65.6

Return on Equity (ttm)

-113.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-21.99

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

1.21

P/S

P/CF

-12.01

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.